Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

John A. Glaspy, Ronald Bukowski, Douglas Steinberg, +3

Journal of Clinical Oncology

The Prognostic Value of the Pathological Response to Combination Chemotherapy before Cystectomy in Patients with Invasive Bladder Cancer

Ted A.W. Splinter, Howard I. Scher, L. Denis, +7

The Journal of Urology

Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas

Vladimir Kolenko, Qing Wang, M.C. Riedy, +9

The Journal of Immunology

Downregulation of JAK3 Protein Levels in T Lymphocytes by Prostaglandin E2 and Other Cyclic Adenosine Monophosphate-Elevating Agents: Impact on Interleukin-2 Receptor Signaling Pathway

Vladimir Kolenko, Patricia Rayman, Biswajit Roy, +6

Blood

The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.

T Splinter, H I Scher, L. Denis, +6

PubMed

UrologySurgical OncologyGenitourinary CancerMedicineCancer Management +7

Heterogeneous Alterations in Human Alloimmunity Associated with Immunization

Meagan Roddy, Michael J. Clemente, Emilio D. Poggio, +7

Transplantation

HistocompatibilityCellular ImmunologyImmunologyImmunodominanceImmunophenotyping +18

Phase Ib trial of a targeted TLR9 CpG immunomodulator (CPG 7909) in advanced renal cell carcinoma (RCC)

J. A. Thompson, Timothy M. Kuzel, Ronald Bukowski, +2

Journal of Clinical Oncology

ImmunologyImmunoeditingPhase Ib TrialImmunotherapeuticsImmunotherapy +14

The T cell death knell: immune-mediated tumor death in renal cell carcinoma.

Robert G. Uzzo, Vladimir Kolenko, Christopher J. Froelich, +6

PubMed

Renal PathologyImmunologyApoptosisCell DeathT Cells +18

Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer

Kumar Rajagopalan, David M. Peereboom, G. Thomas Budd, +5

Investigational New Drugs

UrologyOncologyPhase Ii TrialMedicinePharmacotherapy +3

Apoptotic pathways induced by ixabepilone in paclitaxel-refractory ovarian carcinoma cells

Luis Rojas‐Espaillat, Denise Uyar, Dale Grabowski, +6

Cancer Research

Chemoprevention StrategyGynecologyCell DeathPathologyCancer Biology +15